High prevalence and dependence of centrosome clustering in mesenchymal tumors and leukemia

Nuria Moreno Marín(Instituto Gulbenkian de Ciência), G Marteil(Inserm), Nora Fresmann(Max Delbrück Center), Bernardo P. de Almeida(Research Institute of Molecular Pathology), Katharina Dores(Instituto Gulbenkian de Ciência), Rita Fragoso(Instituto de Medicina Molecular João Lobo Antunes), Joana Cardoso Vaz(Clinical Microbiomics (Denmark)), Jose B. Pereira Leal(Instituto Gulbenkian de Ciência), João Pedro Taborda Barata(Instituto de Medicina Tropical), Susana A. Godinho(Queen Mary University of London), Nuno L. Barbosa‐Morais(Instituto de Medicina Molecular João Lobo Antunes), Mónica Bettencourt‐Dias(Instituto Gulbenkian de Ciência)
bioRxiv (Cold Spring Harbor Laboratory)
March 17, 2023
Cited by 6Open Access
Full Text

Abstract

The presence of supernumerary centrosomes is a hallmark of cancer and is frequently observed in aggressive tumors. Cancer cells with centrosome amplification achieve pseudo-bipolar spindles through specific coping mechanisms in order to survive. However, their distribution and prevalence in cancer remain largely unknown. Here, using the NCI60 panel of cancer cell lines, we show that the presence of coping strategies correlates with centrosome amplification, with the clustering of extra-centrosomes within the two spindle poles being the most widespread mechanism. Moreover, we report an association between centrosome clustering ability and the epithelial-to-mesenchymal transition (EMT) and observe that the induction of mesenchymal characteristics in breast cancer cells with centrosome amplification promotes clustering. Furthermore, we unveil hematological malignancies, which lack epithelial characteristics, as the most proficient in centrosome clustering. Finally, we show that acute lymphoblastic leukemia is particularly sensitive to targeting clustering through inhibition of the spindle assembly checkpoint. Our study reveals how centrosome clustering and EMT collaborate to promote carcinogenesis, suggesting new possibilities to treat tumors with low epithelial characteristics, in particular leukemias.


Related Papers

No related papers found

Powered by citation graph analysis